Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Adults with genetic forms of rickets, such as X-linked hypophosphatemia, can experience hearing changes because impaired bone mineralization affects the small bones and dense bone surrounding the middle and inner ear, sometimes producing conductive or sensorineural hearing loss, tinnitus, ear fullness, or vertigo. Since these changes develop gradually and are easy to dismiss as normal aging, baseline and periodic audiology testing is advised so treatable problems are identified early. There are several factors to consider, including age, disease severity, prior treatment, and coexisting skull or joint involvement, and the important details are explained below. If you have noticed muffled hearing, ringing, pressure, or dizziness, a free, instant, online symptom check takes only a few minutes and helps you translate vague ear symptoms into clear, organized information. That clarity makes your next step easier, whether that means booking an audiologist, contacting your metabolic bone specialist, or seeking prompt care for sudden changes.
Last reviewed for medical accuracy: 08/18/2026
Genetic forms of rickets—most commonly X-linked hypophosphatemic rickets—lead to low phosphate levels, abnormal bone mineralization and growth problems. While these changes are well known in the legs and spine, they also affect the tiny bones and tissues of the middle ear. Over time, adults with hypophosphatemic rickets can develop hearing loss and enthesopathy (abnormal tissue changes where tendons or ligaments attach to bone). Regular audiology checks help detect these changes early, guide treatment and preserve quality of life.
Hypophosphatemic rickets is a genetic disorder characterized by:
Symptoms can include bone pain, muscle weakness, dental problems and short stature. In adults, enthesopathy may develop around the pelvis, knees, heels and—even more subtly—inside the middle ear.
The middle ear contains three tiny bones (ossicles): the malleus, incus and stapes. These ossicles transmit sound vibrations from the eardrum to the inner ear. Proper mineralization keeps them lightweight and mobile. In hypophosphatemic rickets, bone turnover is disrupted:
Over time, these changes can stiffen or deform the ossicles, reducing sound transmission and leading to hearing loss.
Adults with hypophosphatemic rickets may experience:
Research suggests that up to 40–50% of adults with X-linked hypophosphatemic rickets develop some degree of hearing loss by middle age.
Enthesopathy refers to abnormal changes where tendons or ligaments attach to bone. In the ear:
Identifying enthesopathic changes helps audiologists and ENT specialists determine whether surgery (e.g., stapedotomy) or hearing aids may offer the best outcome.
When you schedule a hearing check, you may undergo:
If abnormalities arise, your audiologist may refer you for CT imaging of the temporal bones or to an ear, nose & throat (ENT) specialist for further evaluation.
For a quick, free, online symptom check, consider using the doctor approved Ubie Symptom Checker. It’s a convenient way to log concerns before your appointment. Free, online symptom check, using the doctor approved Ubie Symptom Checker
Depending on your type and severity of hearing loss, treatments may include:
An interdisciplinary team—endocrinologist, audiologist, ENT surgeon—ensures each aspect of your care is coordinated.
Always consult a healthcare professional about new or worsening symptoms, especially if you experience:
For any life-threatening or serious concerns, contact your doctor or go to the nearest emergency department. A timely conversation can make all the difference.
Taking proactive steps—such as regular audiology checks, maintaining your rickets treatment and speaking up about new ear symptoms—helps you stay in control of your hearing health and overall well-being. If you have questions about your symptoms or need guidance on next steps, don’t hesitate to perform a free, online symptom check, using the doctor approved Ubie Symptom Checker. And always speak to a doctor about anything that could be serious or life threatening.
(References)
* Levy RA, Platt N, Aftalion B. Encephalocele of the middle ear. Laryngoscope. 1971 Jan;81(1):126-30. doi: 10.1288/00005537-197101000-00011. PMID: 5091309.
* Lee DB, Roberts M, Bluchel CG, Odell RA. Zirconium: biomedical and nephrological applications. ASAIO J. 2010 Nov-Dec;56(6):550-6. doi: 10.1097/MAT.0b013e3181e73f20. PMID: 21245802.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Ziegler SG, Ferreira CR. Generalized Arterial Calcification of Infancy. GeneReviews(®). 1993. PMID: 25392903.
* Tian C, Harris BS, Johnson KR. Ectopic Mineralization and Conductive Hearing Loss in Enpp1asj Mutant Mice, a New Model for Otitis Media and Tympanosclerosis. PLoS One. 2016;11(12):e0168159. doi: 10.1371/journal.pone.0168159. Epub 2016 Dec 13. PMID: 27959908; PMCID: PMC5154548.
* Lv K, Huang H, Yi X, Chertoff ME, Li C, Yuan B, Hinton RJ, Feng JQ. A novel auditory ossicles membrane and the development of conductive hearing loss in Dmp1-null mice. Bone. 2017 Oct;103:39-46. doi: 10.1016/j.bone.2017.06.007. Epub 2017 Jun 8. PMID: 28603080; PMCID: PMC5568469.
* Mehta CH, Close MF, Dornhoffer JR, Liu YF, Nguyen SA, McRackan TR, Meyer TA. Vitamin D Deficiency, Hypocalcemia, and Hearing Loss in Children. Otol Neurotol. 2020 Aug;41(7):940-947. doi: 10.1097/MAO.0000000000002676. PMID: 32658400.
* Delsmann MM, Peichl J, Yorgan TA, Beil FT, Amling M, Demay MB, Rolvien T. Prevention of Hypomineralization In Auditory Ossicles of Vitamin D Receptor (Vdr) Deficient Mice. Front Endocrinol (Lausanne). 2022;13:901265. doi: 10.3389/fendo.2022.901265. Epub 2022 Jun 6. PMID: 35733772; PMCID: PMC9207527.
* Ovchinnikov AY, Khon EM, Bakotina AV, Miroshnichenko NA, Gronskaia SA, Belaya ZE. [FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity]. Vestn Otorinolaringol. 2023;88(6):91-96. doi: 10.17116/otorino20238806191. PMID: 38153899.
* Burgac E, Yılmaz SD, Bulut FD, Kor D, Kara E, Köseci B, Kaplan İ, Seydaoğlu G, Mert GG, Mungan NÖ. Neurological involvement in 51 cystinosis patients: A single-center experience. Eur J Paediatr Neurol. 2025 Jul;57:50-56. doi: 10.1016/j.ejpn.2025.05.011. Epub 2025 May 31. PMID: 40466322.
* Ocokoljic A, Srivastava S, von Kroge S, Stabach PR, Busse B, Weise K, Oheim R, Rolvien T, Braddock DT. Improvements in hearing loss with bone-targeted enzyme replacement therapy are associated with corrected hypomineralization and osteocyte properties of auditory ossicles in Enpp1-deficient mice. J Bone Miner Res. 2025 Aug 24;40(9):1077-1086. doi: 10.1093/jbmr/zjaf082. PMID: 40495691; PMCID: PMC12406126.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.